Dietmar Fuchs Selected Research

Highly Active Antiretroviral Therapy (HAART)

11/2018	Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.
1/2017	High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid.
2/2014	Evolving character of chronic central nervous system HIV infection.
6/2010	Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.
8/2008	Increased cardiovascular risk in patients with human immunodeficiency virus infection under highly active antiretroviral therapy.
9/2006	Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dietmar Fuchs Research Topics

Disease

77	Inflammation (Inflammations) 01/2023 - 02/2004
54	Infections 05/2024 - 07/2002
45	Neoplasms (Cancer) 01/2021 - 10/2002
25	HIV Infections (HIV Infection) 02/2023 - 09/2002
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2005
12	Dementia (Dementias) 05/2024 - 11/2003
12	Fatigue 05/2023 - 07/2007
12	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2004
10	Obesity 11/2021 - 05/2006
10	Cognitive Dysfunction 01/2021 - 10/2002
10	Disease Progression 01/2019 - 07/2005
10	Atherosclerosis 12/2016 - 05/2002
10	Coronary Artery Disease (Coronary Atherosclerosis) 03/2015 - 10/2003
9	Schizophrenia (Dementia Praecox) 01/2022 - 01/2014
9	Anemia 10/2021 - 02/2006
8	Bipolar Disorder (Manic Depressive Psychosis) 11/2021 - 06/2014
8	Virus Diseases (Viral Diseases) 01/2016 - 10/2002
7	Central Nervous System Infections (Central Nervous System Infection) 12/2021 - 06/2010
7	Overweight 11/2021 - 06/2014
7	Viremia 11/2020 - 11/2007
7	Rheumatoid Arthritis 01/2015 - 09/2003
7	Hyperhomocysteinemia 11/2010 - 11/2003
6	Neuroinflammatory Diseases 01/2022 - 06/2013
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 04/2007
6	Chronic Disease (Chronic Diseases) 01/2020 - 10/2002
6	Asthma (Bronchial Asthma) 08/2019 - 01/2005
6	Carcinoma (Carcinomatosis) 04/2011 - 02/2003
5	Persistent Infection 05/2024 - 09/2011
5	Frailty 11/2023 - 12/2017
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2002
5	Necrosis 01/2018 - 02/2004
5	Wounds and Injuries (Trauma) 11/2010 - 03/2005
5	Coronary Disease (Coronary Heart Disease) 01/2008 - 01/2003
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2024 - 01/2014
4	COVID-19 01/2023 - 12/2020
4	Mental Disorders (Mental Disorder) 01/2022 - 12/2014
4	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2003
4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2002
4	Mood Disorders (Mood Disorder) 01/2019 - 02/2006
4	Hypersensitivity (Allergy) 11/2017 - 01/2005
4	Prostatic Neoplasms (Prostate Cancer) 04/2017 - 02/2003
4	Allergic Rhinitis 01/2016 - 01/2005
4	Brain Injuries (Brain Injury) 01/2014 - 06/2010
4	Sepsis (Septicemia) 03/2011 - 12/2008
3	Major Depressive Disorder (Major Depressive Disorders) 10/2023 - 08/2011
3	Neurologic Manifestations (Neurological Manifestations) 01/2022 - 09/2012
3	Avitaminosis (Vitamin Deficiency) 10/2021 - 11/2003
3	Insulin Resistance 01/2021 - 02/2015
3	Dengue (Dengue Fever) 11/2020 - 09/2006
3	Pneumonia (Pneumonitis) 11/2019 - 01/2014

Drug/Important Bio-Agent (IBA)

105	NeopterinIBA 10/2023 - 05/2002
98	Tryptophan (L-Tryptophan)FDA Link 11/2023 - 09/2002
52	KynurenineIBA 11/2023 - 01/2003
51	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2005
27	CytokinesIBA 01/2023 - 02/2003
21	EnzymesIBA 01/2023 - 01/2006
20	C-Reactive ProteinIBA 01/2023 - 07/2005
20	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2022 - 10/2004
19	HomocysteineIBA 10/2017 - 11/2002
18	Interferon-gamma (Interferon, gamma)IBA 01/2023 - 02/2004
18	Phenylalanine (L-Phenylalanine)FDA Link 01/2023 - 12/2008
16	Interleukin-6 (Interleukin 6)IBA 01/2023 - 02/2003
15	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 12/2008
13	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2010
13	RNA (Ribonucleic Acid)IBA 05/2024 - 09/2006
12	Amino Acids FDA Link 01/2023 - 12/2005
10	AntibodiesIBA 11/2020 - 01/2002
9	Immunoglobulin G (IgG)IBA 11/2023 - 10/2002
9	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023 - 01/2014
9	AntioxidantsIBA 01/2019 - 11/2003
8	Folic Acid (Vitamin M)FDA LinkGeneric 11/2010 - 11/2002
7	NitritesIBA 01/2023 - 07/2011
7	InterferonsIBA 01/2016 - 04/2007
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015 - 12/2003
6	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2014 - 07/2004
6	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2010 - 07/2003
5	LipopolysaccharidesIBA 01/2023 - 08/2009
5	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 05/2006
5	Antiviral Agents (Antivirals)IBA 01/2015 - 04/2009
4	AlbuminsIBA 12/2021 - 04/2004
4	ProcalcitoninIBA 06/2017 - 05/2006
4	Essential Amino AcidsIBA 01/2017 - 12/2008
4	Serum AlbuminIBA 01/2017 - 09/2011
4	Aromatic Amino Acids (Aromatic Amino Acid)IBA 01/2017 - 06/2008
4	Vitamin D FDA LinkGeneric 01/2015 - 12/2012
4	CalciumIBA 01/2012 - 05/2008
3	ProteomeIBA 05/2024 - 03/2012
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2023 - 04/2004
3	Viral RNAIBA 01/2022 - 01/2015
3	Immunoglobulin M (IgM)IBA 01/2022 - 10/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2011
3	IronIBA 10/2021 - 09/2010
3	LeptinIBA 01/2021 - 02/2015
3	Indicators and Reagents (Reagents)IBA 02/2020 - 08/2007
3	LipidsIBA 01/2020 - 05/2002
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 06/2009
3	VitaminsIBA 01/2020 - 11/2010

Therapy/Procedure

31	Therapeutics 05/2023 - 09/2002
8	Art Therapy 02/2023 - 03/2010
6	Highly Active Antiretroviral Therapy (HAART) 11/2018 - 09/2006